In March 2022, member of the Blood Cancer Taskforce and Cancer Australia's Advisory Council Deborah Henderson found out she had COVID-19. Here, she shares her first-person narrative of that experience.
Delighted, really relieved, and excited was Deborah Henderson’s response to her nine-month review following CAR T-cell therapy last year.
Yael Morris was very young – only 34 years old, 28 weeks pregnant, and living in Darwin – when she was diagnosed with CLL 20 years ago.
Dr Piers Blombery specialises in genomic testing and heads Australia’s largest haematology laboratory.
Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.
All Jane Blakely knew about leukaemia was that "people who have leukaemia die".
Updates on three novel therapies for the treatment of CLL and SLL.
Thirty-one days after Deborah Henderson had an infusion of her own re-engineered T-cells in September, she was told her aggressive CLL was in remission and she may well be cured.
Dr Anderson was one of the key researchers involved in the discovery of the live-changing drug, venetoclax (Venclexta®).
Deborah Henderson kissed her children goodbye and moved to London in the hope of getting on a clinical trial.
